These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12210634)

  • 1. Robustness of choice of number of doses for maximum likelihood estimation of the ED(50) in bioassay.
    Huang Y
    Stat Med; 2002 Aug; 21(15):2215-23. PubMed ID: 12210634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choice of number of doses for maximum likelihood estimation of the ED50 for quantal dose-response data.
    Müller HG; Schmitt T
    Biometrics; 1990 Mar; 46(1):117-29. PubMed ID: 2350566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distribution of the maximum likelihood estimator in up-and-down experiments for quantal dose-response data.
    Vågerö M; Sundberg R
    J Biopharm Stat; 1999 Aug; 9(3):499-519. PubMed ID: 10473034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bias reduction in logistic dose-response models.
    Wagler A
    J Biopharm Stat; 2011 May; 21(3):405-22. PubMed ID: 21442516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the error of dose estimates and minimum and maximum acceptable concentrations from assays with nonlinear dose-response curves.
    Gottschalk PG; Dunn JR
    Comput Methods Programs Biomed; 2005 Dec; 80(3):204-15. PubMed ID: 16256244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximum likelihood estimates of mean and variance of occupation radiation doses subjected to minimum detection levels.
    Datta D; Singh S; Johnson BE; Kushwaha HS
    Radiat Prot Dosimetry; 2008; 129(4):411-8. PubMed ID: 18083720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling and simulation in molecular pharmacology.
    Mihalas GI; Kygyosi A; Lungeanu D; Vernic C
    Stud Health Technol Inform; 1998; 52 Pt 1():372-5. PubMed ID: 10384481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining multiple comparisons and modeling techniques in dose-response studies.
    Bretz F; Pinheiro JC; Branson M
    Biometrics; 2005 Sep; 61(3):738-48. PubMed ID: 16135025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A generalization of the probit and logit methods for dose response curves.
    Prentice RL
    Biometrics; 1976 Dec; 32(4):761-8. PubMed ID: 1009225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive designs for dose-finding in non-cancer phase II trials: influence of early unexpected outcomes.
    Resche-Rigon M; Zohar S; Chevret S
    Clin Trials; 2008; 5(6):595-606. PubMed ID: 19029208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating integrals using quadrature methods with an application in pharmacokinetics.
    Bailer AJ; Piegorsch WW
    Biometrics; 1990 Dec; 46(4):1201-11. PubMed ID: 2085635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive urn designs for estimating several percentiles of a dose--response curve.
    Mugno R; Zhus W; Rosenberger WF
    Stat Med; 2004 Jul; 23(13):2137-50. PubMed ID: 15211608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A parametric model for detecting hormetic effects in developmental toxicity studies.
    Hunt DL; Bowman D
    Risk Anal; 2004 Feb; 24(1):65-72. PubMed ID: 15028001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice of designs and doses for early phase trials.
    Zhou Y
    Fundam Clin Pharmacol; 2004 Jun; 18(3):373-8. PubMed ID: 15147290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximum likelihood estimation of correction for dilution bias in simple linear regression using replicates from subjects with extreme first measurements.
    Berglund L; Garmo H; Lindbäck J; Svärdsudd K; Zethelius B
    Stat Med; 2008 Sep; 27(22):4397-407. PubMed ID: 18618419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of genotype error rate using samples with pedigree information--an application on the GeneChip Mapping 10K array.
    Hao K; Li C; Rosenow C; Hung Wong W
    Genomics; 2004 Oct; 84(4):623-30. PubMed ID: 15475239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fitting models for the joint action of two drugs using SAS.
    Whitehead A; Whitehead J; Todd S; Zhou Y; Smith MK
    Pharm Stat; 2008; 7(4):272-84. PubMed ID: 17979217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal adaptive design in clinical drug development: a simulation example.
    Maloney A; Karlsson MO; Simonsson US
    J Clin Pharmacol; 2007 Oct; 47(10):1231-43. PubMed ID: 17906158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonparametric estimation of ROC curves in the absence of a gold standard.
    Zhou XH; Castelluccio P; Zhou C
    Biometrics; 2005 Jun; 61(2):600-9. PubMed ID: 16011710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
    Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
    Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.